Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycoconjugate vaccines for use in immune-compromised populations

Glycoconjugate vaccines for use in immune-compromised populations

US Patent 7449189 · Granted Nov 11, 2008

Estimated economic value: $2,179,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nanoemulsion and methods of use thereof2023
Herpes simplex virus nanoemulsion vaccine2021
Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine2020
Herpes simplex virus nanoemulsion vaccine2019
Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine2017
Human respiratory syncytial virus vaccine2016
Erythropoietin receptor peptide formulations and uses2012
Smoking cessation kit and method2012
Hapten-carrier conjugates for treating and preventing nicotine addiction2011
Hapten-carrier conjugates for treating and preventing nicotine addiction2011
Erythropoietin receptor peptide formulations and uses2011
Erythropoietin receptor peptide formulations and uses2011